Work

A Phase I trial of the farnesyl protein transferase inhibitor R115777 in combination with gemcitabine and cisplatin in patients with advanced cancer.

Year: 2003

Type: article

Study design: Clinical Trial

Source: PubMed

Authors: Alex A Adjei, Gary A Croghan, Charles Erlichman, Randolph S Marks, Joel M Reid, Jeff A Sloan, Henry C Pitot, Steven R Alberts, Richard M Goldberg, Lorelei J Hanson, Laura M Bruzek, Pamela Atherton, Alain Thibault, Peter A Palmer, Scott H Kaufmann

Institutions: Mayo Clinic, Johnson & Johnson (United States)

Language: English

Topic: Protein Kinase Regulation and GTPase Signaling

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Institutes of Health

Awards: General Clinical Research Center, Phase I Clinical Trials of Anticancer Agents

OpenAlex ID: W2163405261

FWCI: 2.788

Cites: 28

Cited by: 52

Related to: 10